HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 968327Generated: October 25, 2026
Hydrochloric Acid → tert-butyl 4-[4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl] phenylaminocarbonyl]piperidine-1-carboxylate
https://huagongshe.com/reaction/968327
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Tetrahydrofuran | HCID 8028 | — |
| Reactant | 1-(tert-Butoxycarbonyl)-4-piperidinecarboxylic acid | HCID 392871 | — |
| Reactant | 4-(3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl)aniline | HCID 2740668 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | tert-butyl 4-[4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl] phenylaminocarbonyl]piperidine-1-carboxylate | HCID 22288408 | 78.9% |
Reaction Steps
A mixture of 1-tert-butoxycarbonylpiperidine-4-carboxylic acid (198 mg), 4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)aniline (206 mg), WSCD hydrochloride (172 mg) and THF (3 ml) was stirred overnight at room temperature. After adding ethyl acetate, the reaction solution was washed with water, saturated sodium bicarbonate aqueous solution, 1 N hydrochloric acid and saturated brine in that order. The organic layer was dried over anhydrous sodium sulfate and then concentrated under a reduced pressure. The resulting residue was purified by silica gel column chromatography (eluent; n-hexane:ethyl acetate=7:1-5:1) to give tert-butyl 4-[4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]phenylaminocarbonyl]piperidine-1-carboxylate (279 mg) as a colorless amorphous solid. 4 N Hydrochloric acid ethyl acetate solution (2.60 ml) was added to a mixture of this solid (263 mg) and ethyl acetate (2.6 ml), followed by stirring at room temperature for 2 hours and 45 minutes. The reaction solution was concentrated under a reduced pressure, diethyl ether was added to the thus obtained residue, and the mixture was concentrated under a reduced pressure. By recrystallizing the resulting residue from a mixed solvent of ethyl acetate and n-hexane, [4′-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]piperidine-4-carboxyanilide hydrochloride (201 mg) was obtained as colorless powder crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06958339B2 |
|---|
| Source dataset | uspto-grants-2005_10 |
|---|
| ORD ID | ord-21ac4db83e794f159bcb47cfe123b5bd |
|---|
| Source note | uspto-grants-2005_10 |
|---|